-+ 0.00%
-+ 0.00%
-+ 0.00%

ALDEYRA THERAPEUTICS SHARES DROP 14.3% PREMARKET AFTER PDUFA EXTENSION OF ITS DRUG CANDIDATE FOR DRY EYE DISEASE TREATMENT

Reuters·12/16/2025 09:14:30

Please log in to view news